CDC - Centers for Disease Control and Prevention (31 Articles with 75,509 total views)
CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.
Of the estimated 1.1 million people living with HIV in the United States, 85 percent were diagnosed and knew they had HIV, and 49 percent had the virus under control through HIV treatment, according to new CDC estimates based on the most recent national data from 2014. CDC previously estimated that in 2010, 28 percent of people living with HIV in America had the virus under control.
Over just five years, the number of new hepatitis C virus infections reported to CDC has nearly tripled, reaching a 15-year high, according to new preliminary surveillance data released today
by the Centers for Disease Control and Prevention (CDC).
February 14, 2017 - The number of annual HIV infections in the United States fell 18 percent between 2008 and 2014 - from an estimated 45,700 to 37,600 - according to new estimates from the Centers for Disease Control and Prevention (CDC)
presented today at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. Progress, however, was not the same among all populations or areas of the country.
February 15, 2017 - A joint modeling study by The Rollins School of Public Health at Emory University and the Centers for Disease Control and Prevention (CDC)
suggests that for gay and bisexual men, pre-exposure prophylaxis (PrEP) for HIV prevention, along with testing for and treatment of sexually transmitted infections (STI), can reduce not only HIV, but also some STIs, even in the presence of some reductions in condom usage.
Statement by Eugene McCray, M.D., Director of the Division of HIV/AIDS Prevention at the National Center for HIV/AIDS Viral Hepatitis, STD and TB Prevention, CDC: This year's National Black HIV/AIDS Awareness Day (February 7) offers us a moment to reflect on the tremendous toll HIV has taken on a generation of African-Americans in this country. It is also an opportunity to recognize the collective progress we've achieved in the African-American community: new diagnoses among African-Americans dropped by 14 percent from 2010 to 2014.
Use of syringe services programs (SSPs) has increased substantially during the past decade, but most people who inject drugs still don't always use sterile needles, according to a new CDC Vital Signs
report published today. Sharing needles and syringes is a direct route of transmission for HIV and hepatitis B and C viruses.
October 19, 2016 - Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual Sexually Transmitted Disease Surveillance Report released today by the Centers for Disease Control and Prevention (CDC)
For the first time in the United States, health officials have identified a cluster of gonorrhea infections that shows both decreased susceptibility to ceftriaxone and very high-level resistance to azithromycin. Ceftriaxone and azithromycin are the two drugs that make up the dual regimen that is the last available effective gonorrhea treatment option. An experimental oral antibiotic being tested in a clinical study may offer a new option for this sexually transmitted disease (STD). The findings were presented today at the 2016 STD Prevention Conference in Atlanta.
September 5, 2016 - Statement from Philip LoBue, M.D., Director, Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC -
Today the U.S. Preventive Services Task Force (USPSTF
) issued a recommendation in the Journal of the American Medical Association
) encouraging providers to test for latent tuberculosis (TB) infection in populations at increased risk. This recommendation will increase efforts to find and treat people who have latent TB infection and is an important step forward in our national strategy for eliminating TB.
The first nationally representative study of U.S. lesbian, gay, and bisexual high school students finds that lesbian, gay, and bisexual students experience substantially higher levels of physical and sexual violence and bullying than other students.
Resistance to azithromycin, a first-line antibiotic used to treat gonorrhea, is emerging, according to CDC
findings published today in the Morbidity and Mortality Weekly Report
.  CDC currently recommends a combination gonorrhea treatment with two antibiotics – an oral dose of azithromycin and single shot of ceftriaxone. Findings released today from CDC’s surveillance system for monitoring the threat of antibiotic-resistant gonorrhea show that the percentage of gonorrhea isolates with decreased susceptibility to azithromycin, an indicator of emerging resistance, increased more than 400 percent between 2013 and 2014 (from 0.6 percent to 2.5 percent of gonorrhea isolates). This is a distressing sign that the future of current treatment options may be in jeopardy and underscores the importance of the federal government’s Combating Antibiotic Resistant Bacteria (CARB) Action Plan
New CDC data presented today at the International AIDS Conference in Durban, South Africa, suggest there are no significant differences in several HIV-related risk behaviors among U.S. male students in ninth through 12th grades who identify as heterosexual, gay, or bisexual. Still, young gay and bisexual males are at much higher risk for HIV because their sex partners are more likely to be infected with HIV.
The rate of women of childbearing age (WCBA) testing positive for hepatitis C increased by 22 percent across the United States between 2011 and 2014 (from 139 to 169 per 100,000 WCBA), according to a new report from the Centers for Disease Control and Prevention (CDC)
. Over the same time period, the national rate of infants born to women living with hepatitis C increased by 68 percent (from 0.19 percent to 0.32 percent).
In the United States, the burden of HIV is disproportionately high for men who have sex with men (MSM), who account for approximately two-thirds of all new diagnoses each year. Results from a new study estimating rates of HIV prevalence (number of people living with an HIV diagnosis) among MSM at local levels highlight areas where gay and bisexual men are at greatest risk for HIV infection. Focusing on these areas will allow health departments and community-based organizations to provide HIV prevention and care resources to MSM who need them most.
New CDC studies underscore urgency of hepatitis C testing and treatment, especially for baby boomers
March 9, 2016- The nation's annual report on cancer
, released today, shows that while we are making substantial progress against cancer overall, a rapidly increasing number of Americans are developing and dying from liver cancer, despite the fact that viral hepatitis – a primary cause of liver cancer – is preventable and treatable.
If current HIV diagnoses rates persist, about 1 in 2 black men who have sex with men (MSM) and 1 in 4 Latino MSM in the United States will be diagnosed with HIV during their lifetime, according to a new analysis by researchers at the Centers for Disease Control and Prevention (CDC)
. The study, presented today at the Conference on Retroviruses and Opportunistic Infections in Boston,
provides the first-ever comprehensive national estimates of the lifetime risk of an HIV diagnosis for several key populations at risk and in every state.
Reaching the National HIV/AIDS Strategy (NHAS) targets for HIV testing and treatment and expanding the use of daily pre-exposure prophylaxis (PrEP) could prevent an estimated 185,000 new HIV infections in the United States by 2020 – a 70 percent reduction in new infections, according to researchers at the Centers for Disease Control and Prevention (CDC).
African Americans living with HIV are less likely than white or Latino Americans to receive consistent, ongoing medical care, according to a new Centers for Disease Control and Prevention (CDC) report published today in Morbidity and Mortality Weekly Report (MMWR). Despite the promising sign of declining HIV diagnoses over the past decade, these findings demonstrate yet another persistent disparity that prolongs the epidemic among African Americans.
Congress has given states and local communities, under limited circumstances, the opportunity to use federal funds to support certain components of syringe services programs. These programs provide sterile injection equipment and may also link individuals to services including HIV and hepatitis C testing and care for those infected, substance abuse treatment, and overdose prevention.
December 6, 2015 - Annual HIV diagnoses in the United States fell by 19 percent from 2005 to 2014, driven by dramatic and continuing declines over the decade among several populations including heterosexuals, people who inject drugs, and African Americans – with the steepest declines among black women. However, the same level of success was not seen among all gay and bisexual men.
December 7, 2015 - The Centers for Disease Control and Prevention (CDC) today unveiled two awareness and education efforts designed to reduce new HIV infections by helping people take charge of their health – a new national HIV testing campaign and the beta version of an online tool to help individuals assess and reduce their risk of acquiring or transmitting HIV. The announcements came at the 2015 National HIV Prevention Conference in Atlanta, Georgia, the only major conference in the United States to focus exclusively on HIV prevention.
December 6, 2015 - Death rates among people living with HIV in some Southern states are three times higher than those living in other parts of the country, according to a new state-by-state analysis on progress in HIV prevention and care released today by the Centers for Disease Control and Prevention (http://www.cdc.gov/nchhstp/newsroom/2015/nhpc.html#RegionalGraphics
Reported cases of three nationally notifiable STDs – chlamydia, gonorrhea, and syphilis – have increased for the first time since 2006, according to data published by the Centers for Disease Control and Prevention (CDC) in the 2014 STD Surveillance Report.
CHICAGO, Sept. 11, 2015 /PRNewswire-USNewswire/ -- On one day, Tuesday, September 22nd, Positively Aware
and TPAN are inviting everyone, regardless of HIV status, to get in the picture and participate in A Day with HIV
, the magazine's sixth annual anti-stigma photo campaign. On 9/22/2015 people across the world, whether HIV-positive or negative, will visually capture and share a moment of their day – A Day with HIV
– to focus attention on what it means to live in a world with HIV.
July 20, 2015 -New CDC
data from Botswana show that both women and men were highly adherent to using daily oral HIV pre-exposure prophylaxis, or PrEP, over the course of a one-year open-label study. Because this study more closely replicated a real-world setting than its preceding clinical trial – since participants received no financial compensation and all were aware they were taking an active drug – the findings may provide a better indication of likely adherence among women and men seeking to use PrEP for HIV prevention.
July 1, 2015 - The Centers for Disease Control and Prevention
announced today that it has awarded $216 million over five years to 90 community-based organizations (CBOs) nationwide to deliver effective HIV prevention strategies to those at greatest risk, including people of color, men who have sex with men (MSM), transgender individuals, and people who inject drugs.
March 31, 2015 - The Centers for Disease Control and Prevention
will lead new programs totaling more than $185 million in HIV prevention funding for men who have sex with men (MSM) and transgender people, with a particular focus on addressing the needs of MSM of color. The multi-faceted strategy will respond to the severe burden of HIV among MSM and transgender men and women through three new programs enabling health departments and local HIV prevention partners to deliver the most effective HIV prevention tools.
February 23, 2015- More than 90 percent of new HIV infections in the United States could be averted by diagnosing people living with HIV and ensuring they receive prompt, ongoing care and treatment. This finding was published today in JAMA Internal Medicine
by researchers at the Centers for Disease Control and Prevention
February 24, 2015 - Today at the Conference on Retroviruses and Opportunistic Infections (CROI), the French national HIV research agency ANRS announced results of the IPERGAY trial, which examined a novel dosing strategy for pre-exposure prophylaxis, or PrEP, among men who have sex with men (MSM). The study evaluated a three-day PrEP regimen of tenofovir plus emtricitabine (brand name Truvada) designed to be taken orally before and after sex. The researchers reported that PrEP reduced HIV risk among the MSM who were prescribed this regimen by an average of 86 percent.